Loading Events

« All Events

  • This event has passed.

The Future of Reimbursement Through the Lens of MedPAC

December 6, 2022 @ 1:00 pm - 2:30 pm EST

Moss Adams CPE Webinars

Participants of the free live webinar will be eligible for 1.5 CPE credits.


The number one concern providers cite is the future of reimbursement. Reimbursement rates haven’t kept up with the rising costs of staffing and health care.

Join us for our webcast, The Future of Reimbursement Through the Lens of MedPAC, to hear from Michael Chernew, Chair of Medicare Payment Advisory Commission (MedPAC), for a discussion on:

  • The current reimbursement climate for health care providers
  • Where the future of reimbursement is headed
  • How leaders across the health care continuum can strategize for 2023 and beyond

Please note, when registering, you’ll be automatically enrolled for both parts of the series. For more information on CPE for both webcasts, download the CPE details.

CPE Information

CREDITS: Business Management & Organization: 1.5

After completing this training, participants will be able to describe the current reimbursement climate for health care providers from the perspective of MedPAC; explain predictions for the future of Medicare reimbursement over the next five years and beyond; and list three ways providers and payers ought to strategize for declining reimbursement from both CMS and commercial providers in the future.


For more information about administrative policies regarding CPE, refunds or complaints, please contact Michaella Johnson at (503) 478-2289 or send them an email.

Moss Adams is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State Boards of Accountancy have the final authority on the acceptance of individual course for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org.


Leave a Reply

Subscribe Here